INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

Development and validation of a yeast high-throughput screen for inhibitors of A{beta}42 oligomerization

Show simple item record

Bookmark or cite this item: http://hdl.handle.net/10027/8495

Files in this item

File Description Format
PDF dmm.007963.full.pdf (1MB) (no description provided) PDF
Title: Development and validation of a yeast high-throughput screen for inhibitors of A{beta}42 oligomerization
Author(s): Park, Sei-Kyoung; Pegan, Scott D.; Mesecar, Andrew D.; Jungbauer, Lisa M.; LaDu, Mary Jo; Liebman, Susan W.
Subject(s): oligomers high-throughput screen
Abstract: Recent reports point to small soluble oligomers, rather than insoluble fibrils, of amyloid β (Aβ), as the primary toxic species in Alzheimer’s disease. Previously, we developed a low-throughput assay in yeast that is capable of detecting small Aβ42 oligomer formation. Specifically, Aβ42 fused to the functional release factor domain of yeast translational termination factor, Sup35p, formed sodium dodecyl sulfate (SDS)-stable low-n oligomers in living yeast, which impaired release factor activity. As a result, the assay for oligomer formation uses yeast growth to indicate restored release factor activity and presumably reduced oligomer formation. We now describe our translation of this assay into a high-throughput screen (HTS) for anti-oligomeric compounds. By doing so, we also identified two presumptive anti-oligomeric compounds from a sub-library of 12,800 drug-like small molecules. Subsequent biochemical analysis confirmed their anti-oligomeric activity, suggesting that this form of HTS is an efficient, sensitive and cost-effective approach to identify new inhibitors of Aβ42 oligomerization.
Issue Date: 2011-08-02
Publisher: Company of Biologists
Citation Info: Park, S. K., Pegan, S. D., Mesecar, A. D., Jungbauer, L. M., Ladu, M. J., & Liebman, S. W. 2011. Development and validation of a yeast high-throughput screen for inhibitors of A{beta}42 oligomerization. Disease Models and Mechanisms. DOI: 10.1242/dmm.007963.
Type: Article
Description: © 2011. Published by The Company of Biologists Ltd This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms. DOI: 10.1242/dmm.007963.
URI: http://hdl.handle.net/10027/8495
ISSN: 1754-8403
Sponsor: This work was supported by grants to S.W.L. from the Alzheimer’s Association (IIRG-06-25468 and IIRG-10-173736) and the NIH (R21 AG02881). The authors are grateful to Dennis Selkoe (Harvard Medical School, Boston, MA) for kindly providing RS-0406 and to David Scopes (Senexis Limited, UK) for kindly providing SEN304 and SEN1269.
Date Available in INDIGO: 2012-08-16
 

This item appears in the following Collection(s)

Show simple item record

Statistics

Country Code Views
United States of America 123
China 51
United Kingdom 4
Netherlands 2
Belgium 1

Browse

My Account

Information

Access Key